Accuray Inc
3 nominees · 4 ballot items.
Election of three Class I directors; approval of Accuray Incorporated 2026 Equity Incentive Plan; advisory vote to approve compensation of named executive officers; and ratification of Grant Thornton LLP as independent registered public accounting firm.
Follow how the vote landed and what changed on Accuray Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of Class I Directors
ManagementBoard: FORElection of three Class I directors to hold office until the 2028 Annual Meeting; nominees are Anne B. Le Grand, Joseph E. Whitters and Chan W. Galbato (Class I nominee if elected).
- 2
Approval of the Accuray Incorporated 2026 Equity Incentive Plan
ManagementBoard: FORProposal to approve the Accuray Incorporated 2026 Equity Incentive Plan, which would reserve 3,896,000 shares for issuance, plus shares eligible to be added from the prior 2016 Plan; the plan provides for stock options, restricted stock, RSUs, PSUs, and other awards; administration by the Board or a committee; termination of the 2016 Plan upon effectiveness; includes governance features (no evergreen, minimum vesting, clawbacks, Change in Control provisions) and potential French-qualified RSUs under Macron regime.
- 3
Advisory Vote to Approve the Compensation of Our Named Executive Officers (SAY-ON-PAY
ManagementBoard: FORAdvisory (non-binding) vote to approve the compensation of our named executive officers as disclosed in the Proxy Statement.
- 4
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatification of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026; not required by law but presented as a matter of good governance; audit committee oversight; and related fees.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | TCW GROUP INC | 15.9% | 18,942,059 | $4M |
| 2 | Neuberger Berman Group LLC | 5.1% | 6,073,663 | $2M |
| 3 | ARMISTICE CAPITAL, LLC | 4.8% | 5,736,000 | $1M |
| 4 | WEBER CAPITAL MANAGEMENT LLC /ADV | 4.1% | 4,932,706 | $1M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 4,437,800 | $1M |
| 6 | AQR CAPITAL MANAGEMENT LLC | 2.2% | 2,650,286 | $683K |
| 7 | BlackRock, Inc. | 1.8% | 2,202,735 | $568K |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 1.7% | 2,065,284 | $532K |
| 9 | DAFNA Capital Management LLC | 1.4% | 1,680,508 | $433K |
| 10 | MILLENNIUM MANAGEMENT LLC | 1.3% | 1,589,145 | $410K |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Accuray Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Accuray Inc 2025 annual meeting?
- Accuray Inc (ARAY) holds its 2025 annual shareholder meeting on Thursday, November 13, 2025.
- What is the record date for the Accuray Inc 2025 meeting?
- The record date for the Accuray Inc 2025 meeting is Wednesday, September 17, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Accuray Inc's 2025 meeting?
- The board is presenting 3 director nominees at the Accuray Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Accuray Inc 2025 meeting?
- Shareholders will vote on 4 proposals at the Accuray Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.